Skip to main content
SpringerLink
Log in

Assessment of Adriamycin cardiotoxicity in children by systolic time intervals

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

In a prospective study, 44 children receiving Adriamycin (ADR) for various neoplastic diseases underwent serial estimations of the systolic time intervals (STI) for the noninvasive assessment of left ventricular myocardial performance. Five of the 44 children developed clinical signs of ADR-related congestive heart failure at a cumulative dose of less than 550 mg/m2 body surface area. Clinical symptoms, changes in the electrocardiogram and in the chest X-ray were preceded in every case by changes of the STI, mainly a prolongation of the left ventricular pre-ejection period (PEP), or a decrease of the ejection time (ET)/pre-ejection period (PEP) ratio (ET/PEP). A continous increase of the PEP and a decrease of the ET/PEP-ratio also gave an indication of myocardial dysfunction during ADR treatment in the other children without clinical signs of congestive heart failure. This subclinical cardiotoxic effect of ADR below the critical cumulative dose of 550 mg/m2 was observed in children with pre-existent myocardial damage, with preceding thoracic irradiation, or during concurrent chemotherapy, of which cyclophosphamide seemed to be most important. Thus, the estimation of the STI proved helpful and reliable in the early detection of incipient heart failure and in the selection of high risk patients in children receiving ADR treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Balcerzak, S. P., Christakis, J., Lewis, R. P., Olson, H. M., Malspeis, L.: Systolic time intervals in monitoring adriamycin-induced cardiotoxicity. Cancer Treat. Rep. 62, 893 (1978)

    Google Scholar 

  2. Benjamin, R. S.: A practical approach to adriamycin toxicology. Cancer Chemother. Rep. 3, 6, 191 (1975)

    Google Scholar 

  3. Billingham, M. E., Bristow, M. R., Mason, J. W., Daniels, J. R.: Endomyocardial biopsy evidence of radiation enhancement of adriamycin cardiotoxicity. Circulation 54, Suppl. II: 23 (1976)

    Google Scholar 

  4. Billingham, M., Bristow, M., Mason, J., Friedman, M.: Endomyocardial biopsy findings in adriamycin-treated patients. The twelfth annual meeting of the American Society of Clinical Oncology, Toronto, May 4–5, 1976

  5. Björkhem, G., Garwicz, S.: Echocardiographic assessment of left ventricular function during the injection of adriamycin. Acta Paediatr. Scand. 66, 595 (1977)

    Google Scholar 

  6. Buckner, C. D., Rudolph, R. H., Fefer, A.: High dose cyclophosphamide therapy for malignant disease. Cancer 29, 357 (1972)

    Google Scholar 

  7. Cassady, J. R., Richter, M. P., Piro, A. J., Jaffe, N.: Radiation-adriamycin interactions: Preliminary clinical observations. Cancer 36, 949 (1975)

    Google Scholar 

  8. Christakis, J., Lewis, R., Balcerzak, S.: Monitoring of adryamycin cardiotoxicity by systolic time intervals. The twelfth annual meeting of the American Society of Clinical Oncology, Toronto, May 4–5, 1976

  9. Cortes, E. P., Holland, J. F., Wang, J. J., Sinks, L. F., Blom, J., Senn, H., Bank, A., Glidewell, O.: Amputation and adriamycin in primary osteosarcoma. N. Engl. J. Med. 291, 998 (1974)

    Google Scholar 

  10. Cortes, E. P., Lutman, G., Wanka, J., Wang, J. J., Pickren, J., Wallace, J., Holland, J. F.: Adriamycin cardiotoxicity: A clinicopathologic correlation. Cancer Chemother. Rep. 3, 6, 215 (1975)

    Google Scholar 

  11. Fulkerson, P. K., Talley, R., Kleinmann, D., Weaver, S. K., Leier, C. V., Balcerzak, S. P., Lewis, R. P.: Noninvasive profile in the prospective monitoring of adriamycin cardiomyopathy. Cancer Treat. Rep. 62, 881 (1978)

    Google Scholar 

  12. Gerber, M. A., Gilbert, E. M., Chung, K. J.: Adriamycin cardiotoxicity in a child with Wilms tumor. J. Pediat. 87, 629 (1975)

    Google Scholar 

  13. Ghavimi, F., Exelby, P. R., D'Angio, G. J., Cham, W., Lieberman, P. H., Tan, C., Mike, V., Murphy, M. L.: Multidisciplinary treatment of embryonal rhabdomyosarcoma in children. Cancer 35, 677 (1975)

    Google Scholar 

  14. Gilladoga, A. C., Corazon, M., Tan, C. C., Wollner, N., Murphy, M. L.: Cardiotoxicity of adriamycin in children. Cancer Chemother. Rep. 3, 6, 209 (1975)

    Google Scholar 

  15. Gilladoga, A. C., Manuel, C., Tan, C. C., Wollner, N., Sternberg, S. S., Murphy, M. L.: The cardiotoxicity of adriamycin and daunomycin in children. Cancer 37, 1070 (1976)

    Google Scholar 

  16. Gilladoga, A. C., Tan, C. C., Murphy, M. L., Thaler, H.: Echocardiographic assessment of left ventricular function in children receiving adriamycin (ADR) or daunorubicin (DNR). Ped. Res. 10, 453 (1976)

    Google Scholar 

  17. Golde, D., Burstin, L.: Systolic phases of the cardiac cycle in children. Circulation 42, 1029 (1970)

    Google Scholar 

  18. Gottdiener, J. S.: Noninvasive assessment of cardiac dysfunction in the cancer patient. Cancer Treat. Rep. 62, 949 (1978)

    Google Scholar 

  19. Gupta, M., Cortes, E. P., Mundia, A.: Systolic time intervals in adriamycin-treated patients on digoxin or prednison cardioprophylaxis. The twelfth annual meeting of the American Society of Clinical Oncology, Toronto, May 4–5, 1976

  20. Heller, R. M., Sang, Oh K., Kaizer, H., Musikabhumme, A.: Radiologic recognition of adriamycin cardiotoxicity. Pediat. Radiol. 5, 44 (1976)

    Google Scholar 

  21. Henderson, C., Sloss, L. J., Jaffe, N., Blum, R. H., Frei III, E.: Serial studies of cardiac function in patients receiving adriamycin. Cancer Treat. Rep. 62, 923 (1978)

    Google Scholar 

  22. Hoff, D. D. van, Rozencweig, M., Layard, M., Slavik, M., Muggia, F. M.: Daunomycininduced cardiotoxicity in children and adults. Am. J. Med. 62, 200 (1977)

    Google Scholar 

  23. Hutchinson, R. J., Bailey, C., Wood, D., Donaldson, M. H.: Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients. Cancer Treat. Rep. 62, 907 (1978)

    Google Scholar 

  24. Lefrak, E. A., Pitha, J., Rosenheim, S., Gottlieb, J. A.: A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32, 302 (1973)

    Google Scholar 

  25. Lenaz, L., Page, J. A.: Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat. Rev. 3, 111 (1976)

    Google Scholar 

  26. Long, H. J., Zeidner, S. R., Burningham, R. A.: Enhanced cardiomyopathy in rabbits receiving adriamycin and cardiac irradiation. The twelfth annual meeting of the American Society of Clinical Oncology, Toronto, May 4–5, 1976

  27. Löser, H., Pfister, S., Fischbach, H., Apitz, J.: Untersuchungen zur kardiotoxischen Wirkung des Cytostatikums Adriamycin. Pädiat. Prax. 18, 233 (1977)

    Google Scholar 

  28. Minow, R. A., Benjamin, R. S., Gottlieb, J. A.: Adriamycin (NSC-123127) cardiomyopathy — an overview with determination of risk factors. Cancer Chemother. Rep. 3, 6, 195 (1975)

    Google Scholar 

  29. Minow, R. A., Gottlieb, J. A., Frazin, L., Garcia, E.: Adriamycin Cardiotoxicity. Ann. Intern. Med. 82, 855 (1975)

    Google Scholar 

  30. Minow, R. A., Benjamin, R. S., Lee, E. T., Gottlieb, J. A.: QRS voltage change with adriamycin administration. Cancer Treat. Rep. 62, 931 (1978)

    Google Scholar 

  31. Prout, M. N., Richards, M. J., Chung, K. J., Joo, P., Davis Jr., H. L.: Adriamycin cardiotoxicity in children. Cancer 39, 62 (1977)

    Google Scholar 

  32. Ragab, A. H., Sutow, W. W., Komp, D. M., Starling, K. A., Lyon, G. M., George, S.: Adriamycin in the treatment of childhood acute leukemia. Cancer 36, 1223 (1975)

    Google Scholar 

  33. Ramos, A., Meyer, R. A., Korfhagen, J., Wong, Y., Kaplan, S.: Echocardiographic evaluation of adriamycin cardiomyopathy in children. Pediat. Res. 10, 456 (1976)

    Google Scholar 

  34. Riehm, H., Gadner, H., Welte, K.: Die West-Berliner Studie zur Behandlung der akuten lymphoblastischen Leukämie des Kindes. Klin. Pädiat. 189, 89 (1977)

    Google Scholar 

  35. Rinehart, J. J., Lewis, R. P., Balcerzak, S. P.: Adriamycin cardiotoxicity in man. Ann. Intern. Med. 81, 475 (1974)

    Google Scholar 

  36. Rosen, G., Wollner, N., Tan, C., Wu, S. J., Hajdu, S. I., Cham, W., D'Angio, G. J., Murphy, M. L.: Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy. Cancer 33, 384 (1974)

    Google Scholar 

  37. Stopfkuchen, H., Gutjahr, P.: Adriamycin-Kardiomyopathie bei einem Kind mit Wilms-Tumor und Lebermetastasen. Klin. Pädiat. 188, 459 (1976)

    Google Scholar 

  38. Sutow, W. W., Vietti, T. J., Fernbach, D. J.: Clinical pediatric oncology. Saint Louis: C. V. Mosby Company 1973

    Google Scholar 

  39. Tan, C., Gilladoga, A., Ghavimi, F., Rosen, G., Haghbin, M., Wollner, N., Helson, L., Murphy, M. L.: Adriamycin alone and in combination in the treatment of childhood neoplastic diseases. In: Ergebnisse der Adriamycin-Therapie, M. Ghione, J. Fetzer, H. Maier (eds.). Berlin-Heidelberg-New York: Springer 1975

    Google Scholar 

  40. Weissler, A. M., Harris, W. S., Schoenfeld, C. D.: Bedside technics for the evaluation of ventricular function in man. Am. J. Cardiol. 23, 577 (1969)

    Google Scholar 

  41. Wilcox, R. G., James, P. D., Toghill, P. J.: Endomyocardial fibrosis associated with daunorubicin therapy. Br. Heart J. 38, 860 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatric Cardiology and Section of Paediatric Oncology, University Children's Hospital, University of Heidelberg, Im Neuenheimer Feld 150, D-6900, Heidelberg, Federal Republic of Germany

    H. E. Ulmer, R. Ludwig & H. Geiger

Authors
  1. H. E. Ulmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Ludwig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Geiger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ulmer, H.E., Ludwig, R. & Geiger, H. Assessment of Adriamycin cardiotoxicity in children by systolic time intervals. Eur J Pediatr 131, 21–31 (1979). https://doi.org/10.1007/BF00442782

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442782

Key words

Search

Navigation